Among gastric cancer patients with irAEs, the gut microbiome showed reduced but not yet significant alpha diversity along with the irAE severity ( Supplementary Figure 2A ).
← all excerpts
Correlation of the gut microbiome and immune-related adverse events in gastrointestinal cancer patients treated with immune checkpoint inhibitors.
1
—
—